
Startups
Radiology Claims 76% Of FDA-Cleared Medical AI, Study Finds
A peer-reviewed analysis of 1,430 FDA authorization records shows three review panels account for more than 90% of AI-enabled medical devices.
Bootstrapped Wealth reported on Cureus on October 7, 2026.
October 7, 2026
The analysis, published in Cureus on July 13, 2026 and written by GigHz founder Pouyan Golshani and Mary S. Joseph, reviewed 1,430 entries on the FDA's public list of AI- and machine-learning-enabled devices authorized between September 1995 and December 2025.

Startups
A peer-reviewed analysis of 1,430 FDA authorization records shows three review panels account for more than 90% of AI-enabled medical devices.